RAND Medal Recipients
|
1993 |
GAR Johnston |
GABA Receptors – As Complex as ABC? |
|
1995 |
S Pond |
Illumination of Therapeutics by Toxicology |
|
1997 |
B Jarrott |
Design and serendipity in the quest for novel neuroprotective drugs |
|
1999 |
D Birkett |
Peripatetic paths in research: from biochemistry via drug metabolism to drug utilisation |
|
2001 |
JO Miners |
The evolution of drug metabolism: Hitchhiking on the technology bandwagon |
|
2003 |
R Summers |
The Janus faces of adrenoceptors |
|
2005 |
G Burnstock |
Purinergic Signalling’: history and therapeutic potential |
|
2007 |
M Roberts |
Seeking to Improve Therapeutic Outcomes Through Research |
|
2009 |
P Beart P Mackenzie |
Design and Serendipity in Pursuit of Neuroprotection The UDP Glycosyltransferases; a Versatile Defense Against Chemical Insult |
|
2011 |
G Dusting |
Adventures in Pharmacology: From prostaglandins to tissue engineering and a bionic eye |
|
2013 |
A Christopoulos |
Reciprocal relationships: The role of ‘topography’ in drug discovery |
|
2015 |
D Le Couteur |
The Greenfields of Geriatric Pharmacology |
|
2017 |
N Buckley |
Optimising medicines for optimal patient outcomes? Perhaps we need more comparative ineffectiveness research! |
|
2019 |
P Sexton |
Molecular and structural basis of the allosteric control of GPCR phenotype by receptor activity-modifying proteins (RAMPs) |
|
2021 |
C Sobey |
From vasomotor mechanisms to oxidative stress, to inflammation and cardiovascular therapies: With a lot of help from my friends. |
|
2023 |
D Hoyer |
From Serotonin to Neuropeptides and back: Translational Research in Pharma and Academia |